Latest News about Large Cap
Recent news which mentions Large Cap
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
November 15, 2024
From Benzinga
From Benzinga
UnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape
November 14, 2024
From Benzinga
GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why
November 14, 2024
From Benzinga
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's Detailed Phase 3 Data Shows
November 14, 2024
From Benzinga
Trump Rally Fades As Investors Await Powell's Remarks, Bitcoin Drops Below $90,000: What's Driving Markets Thursday?
November 14, 2024
From Benzinga
From Benzinga
Golden Years For M&A Deals Ahead Under Trump? Analysts Highlight Top 10 Large-Cap Candidates
November 14, 2024
From Benzinga
Ovintiv Shakes Up Portfolio With $2.38 Billion Montney Acquisition And $2 Billion Uinta Basin Sale, Pauses Buyback
November 14, 2024
From Benzinga
Mastercard's 2030 Vision: A Future Without Passwords, Card Numbers
November 14, 2024
From Benzinga
General Mills Dives Deeper Into Pet Market With This $1.45 Billion Acquisition: Details
November 14, 2024
From Benzinga
From Benzinga
Tetra Tech's Q4 Revenue Soars, But Shares Dip On Soft Guidance For 2025
November 14, 2024
From Benzinga
Tapestry And Capri Call Off $8.5B Deal Amid Legal Hurdles
November 14, 2024
From Benzinga
Mali Demands $162 Million From Resolution, Trading Suspended
November 14, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free